Century Therapeutics IPSC reported its Q3 earnings results on Thursday, November 9, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Century Therapeutics missed estimated earnings by 7.84%, reporting an EPS of $-0.55 versus an estimate of $-0.51.
Revenue was down $2.08 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 4.91% drop in the share price the next day.
Here's a look at Century Therapeutics's past performance:
Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
---|---|---|---|---|
EPS Estimate | -0.54 | -0.52 | -0.59 | -0.59 |
EPS Actual | -0.56 | -0.53 | -0.55 | -0.53 |
Revenue Estimate | 1.14M | 1.31M | 1.97M | 1.13M |
Revenue Actual | 99K | 1.72M | 521K | 2.22M |
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Century Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.